Iranian Pediatric COVID-19 Epidemiology and Clinical Characteristics
Background. Despite the worldwide spread of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2), information about the epidemiological and clinical patterns of this infection is still largely unknown in children. In addition, the prevalence of this disease is still very high in some parts...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2021/4914371 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832559128778637312 |
|---|---|
| author | Shahnaz Armin Mohammadreza Mirkarimi Zahra Pourmoghaddas Marjan Tariverdi Azadeh Jafrasteh Noushin Marhamati Armin Shirvani Abdollah Karimi Sedigheh Rafiei Tabatabaei Roxana Mansour Ghanaei SeyedAlireza Fahimzad Fariba Shirvani Seyedeh Mahsan Hoseini-Alfatemi |
| author_facet | Shahnaz Armin Mohammadreza Mirkarimi Zahra Pourmoghaddas Marjan Tariverdi Azadeh Jafrasteh Noushin Marhamati Armin Shirvani Abdollah Karimi Sedigheh Rafiei Tabatabaei Roxana Mansour Ghanaei SeyedAlireza Fahimzad Fariba Shirvani Seyedeh Mahsan Hoseini-Alfatemi |
| author_sort | Shahnaz Armin |
| collection | DOAJ |
| description | Background. Despite the worldwide spread of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2), information about the epidemiological and clinical patterns of this infection is still largely unknown in children. In addition, the prevalence of this disease is still very high in some parts of the world, including Iran. Thus, this study aims to evaluate the epidemiological features, laboratory and imaging findings, and the type of treatments in children with novel coronavirus 2019 (COVID-19). Method. This study is conducted from March 2020–March 2021 by using the medical records of hospitalized confirmed COVID-19 children younger than 18 years in five cities of Iran: Tehran, Ahwaz, Isfahan, Bandar-Abbas, and Khorramabad. In addition to demographic and epidemiological data, we also studied clinical signs and treatments. Results. In total 278 confirmed COVID-19 children, the average age was 5.3 years, and 59.4%were boys. A total of 37.8% had an underlying disease, in which the most common was a malignancy. The most common symptoms were fever and cough. In this group of pediatrics, some abnormal laboratory findings have been seen. GGO (Ground-Glass Opacity) had been diagnosed in 58.6% of children. 3.6% needed oxygen therapy with ventilators, and 83.09% had received antibiotic treatments with the majority of ceftriaxone. Also, 10% had got steroids. In this study, the mortality rate was 4.3%. Conclusion. In this study, most of the children who died had an underlying disease, so timely care and action is important in them. Most children admitted to our study received antibiotics and were prescribed antivirals and steroids for a smaller number. Also, a small number of children received oxygen therapy, most of whom were in the age group of 1 to 5 years. |
| format | Article |
| id | doaj-art-2c471e6b992644efb52664d4c3248d65 |
| institution | Kabale University |
| issn | 1918-1493 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases and Medical Microbiology |
| spelling | doaj-art-2c471e6b992644efb52664d4c3248d652025-02-03T01:30:40ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1918-14932021-01-01202110.1155/2021/4914371Iranian Pediatric COVID-19 Epidemiology and Clinical CharacteristicsShahnaz Armin0Mohammadreza Mirkarimi1Zahra Pourmoghaddas2Marjan Tariverdi3Azadeh Jafrasteh4Noushin Marhamati5Armin Shirvani6Abdollah Karimi7Sedigheh Rafiei Tabatabaei8Roxana Mansour Ghanaei9SeyedAlireza Fahimzad10Fariba Shirvani11Seyedeh Mahsan Hoseini-Alfatemi12Pediatric Infections Research CenterAboozar Children’s Medical CenterPediatrics Infectious Disease DepartmentDepartment of PediatricDepartment of PediatricsPediatric Infections Research CenterVirtual School of Medical Education and ManagementPediatric Infections Research CenterPediatric Infections Research CenterPediatric Infections Research CenterPediatric Infections Research CenterPediatric Infections Research CenterPediatric Infections Research CenterBackground. Despite the worldwide spread of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2), information about the epidemiological and clinical patterns of this infection is still largely unknown in children. In addition, the prevalence of this disease is still very high in some parts of the world, including Iran. Thus, this study aims to evaluate the epidemiological features, laboratory and imaging findings, and the type of treatments in children with novel coronavirus 2019 (COVID-19). Method. This study is conducted from March 2020–March 2021 by using the medical records of hospitalized confirmed COVID-19 children younger than 18 years in five cities of Iran: Tehran, Ahwaz, Isfahan, Bandar-Abbas, and Khorramabad. In addition to demographic and epidemiological data, we also studied clinical signs and treatments. Results. In total 278 confirmed COVID-19 children, the average age was 5.3 years, and 59.4%were boys. A total of 37.8% had an underlying disease, in which the most common was a malignancy. The most common symptoms were fever and cough. In this group of pediatrics, some abnormal laboratory findings have been seen. GGO (Ground-Glass Opacity) had been diagnosed in 58.6% of children. 3.6% needed oxygen therapy with ventilators, and 83.09% had received antibiotic treatments with the majority of ceftriaxone. Also, 10% had got steroids. In this study, the mortality rate was 4.3%. Conclusion. In this study, most of the children who died had an underlying disease, so timely care and action is important in them. Most children admitted to our study received antibiotics and were prescribed antivirals and steroids for a smaller number. Also, a small number of children received oxygen therapy, most of whom were in the age group of 1 to 5 years.http://dx.doi.org/10.1155/2021/4914371 |
| spellingShingle | Shahnaz Armin Mohammadreza Mirkarimi Zahra Pourmoghaddas Marjan Tariverdi Azadeh Jafrasteh Noushin Marhamati Armin Shirvani Abdollah Karimi Sedigheh Rafiei Tabatabaei Roxana Mansour Ghanaei SeyedAlireza Fahimzad Fariba Shirvani Seyedeh Mahsan Hoseini-Alfatemi Iranian Pediatric COVID-19 Epidemiology and Clinical Characteristics Canadian Journal of Infectious Diseases and Medical Microbiology |
| title | Iranian Pediatric COVID-19 Epidemiology and Clinical Characteristics |
| title_full | Iranian Pediatric COVID-19 Epidemiology and Clinical Characteristics |
| title_fullStr | Iranian Pediatric COVID-19 Epidemiology and Clinical Characteristics |
| title_full_unstemmed | Iranian Pediatric COVID-19 Epidemiology and Clinical Characteristics |
| title_short | Iranian Pediatric COVID-19 Epidemiology and Clinical Characteristics |
| title_sort | iranian pediatric covid 19 epidemiology and clinical characteristics |
| url | http://dx.doi.org/10.1155/2021/4914371 |
| work_keys_str_mv | AT shahnazarmin iranianpediatriccovid19epidemiologyandclinicalcharacteristics AT mohammadrezamirkarimi iranianpediatriccovid19epidemiologyandclinicalcharacteristics AT zahrapourmoghaddas iranianpediatriccovid19epidemiologyandclinicalcharacteristics AT marjantariverdi iranianpediatriccovid19epidemiologyandclinicalcharacteristics AT azadehjafrasteh iranianpediatriccovid19epidemiologyandclinicalcharacteristics AT noushinmarhamati iranianpediatriccovid19epidemiologyandclinicalcharacteristics AT arminshirvani iranianpediatriccovid19epidemiologyandclinicalcharacteristics AT abdollahkarimi iranianpediatriccovid19epidemiologyandclinicalcharacteristics AT sedighehrafieitabatabaei iranianpediatriccovid19epidemiologyandclinicalcharacteristics AT roxanamansourghanaei iranianpediatriccovid19epidemiologyandclinicalcharacteristics AT seyedalirezafahimzad iranianpediatriccovid19epidemiologyandclinicalcharacteristics AT faribashirvani iranianpediatriccovid19epidemiologyandclinicalcharacteristics AT seyedehmahsanhoseinialfatemi iranianpediatriccovid19epidemiologyandclinicalcharacteristics |